Investing.com -- McKesson (NYSE:MCK), a diversified healthcare services company, has announced plans to acquire an 80% stake in PRISM Vision Holdings for $850 million.
The eye-health company's physicians will maintain a 20% interest in the business. This move was announced on Tuesday and is part of McKesson's strategy to develop a platform for retinal and ophthalmology care.
Brian Tyler, McKesson's chief executive, said the acquisition would bolster its community practice and specialty solutions. Furthermore, it aims to create a platform that can cater to the high-growth areas of retina and ophthalmology.
"We intend to develop a leading platform for retinal care, delivering differentiated solutions and value across providers, biopharma partners and patients," Tyler said.
Financially, McKesson predicts that the addition of PRISM Vision will contribute between 20 to 30 cents to its adjusted earnings per share in the first year following the transaction's closure.
By the end of the third year, this accretion is expected to increase to between 65 and 75 cents.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.